12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Pantarhei, Actavis deal

Pantarhei sold its 30% stake in the Estetra S.A. JV to partner Actavis' Uteron Pharma S.A. for an undisclosed combination of cash and stock. Pantarhei is also eligible for milestones. The JV was formed by Pantarhei...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >